S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
66,000% upside on tiny biotech? (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
66,000% upside on tiny biotech? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
66,000% upside on tiny biotech? (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
66,000% upside on tiny biotech? (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
66,000% upside on tiny biotech? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
66,000% upside on tiny biotech? (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
66,000% upside on tiny biotech? (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
66,000% upside on tiny biotech? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
66,000% upside on tiny biotech? (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
66,000% upside on tiny biotech? (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
66,000% upside on tiny biotech? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
66,000% upside on tiny biotech? (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
NASDAQ:ALIM

Alimera Sciences (ALIM) Earnings Date, Estimates & Call Transcripts

$3.10
0.00 (0.00%)
(As of 09/29/2023 ET)
Compare
Today's Range
$3.03
▼
$3.18
50-Day Range
$3.01
▼
$3.59
52-Week Range
$1.30
▼
$6.25
Volume
1,757 shs
Average Volume
58,843 shs
Market Capitalization
$27.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.83
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Nov. 13Estimated
Actual EPS
(Aug. 10)
-$0.44 Missed By -$0.50
Consensus EPS
(Aug. 10)
$0.06
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

ALIM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ALIM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Alimera Sciences Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20231($0.58)($0.58)($0.58) 
Q2 20231($0.22)($0.22)($0.22) 
Q3 20231($0.41)($0.41)($0.41) 
Q4 20231($0.45)($0.45)($0.45) 
FY 20234($1.66)($1.66)($1.66) 
Q1 20241$0.07$0.07$0.07 
Q2 20241$0.09$0.09$0.09 
Q3 20241$0.10$0.10$0.10 
Q4 20241$0.13$0.13$0.13 
FY 20244$0.39$0.39 $0.39

ALIM Earnings Date and Information

Alimera Sciences last posted its quarterly earnings results on August 10th, 2023. The biopharmaceutical company reported ($0.44) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by $0.50. The firm had revenue of $17.54 million for the quarter, compared to analyst estimates of $20.36 million. Alimera Sciences has generated ($3.32) earnings per share over the last year (($3.32) diluted earnings per share). Earnings for Alimera Sciences are expected to grow in the coming year, from ($0.01) to $0.39 per share. Alimera Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 13th, 2023 based off prior year's report dates.

Alimera Sciences Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/13/2023
Estimated)		------- 
8/10/2023Q2 2023$0.06($0.44)($0.50)$0.44$20.36 million$17.54 million
5/15/2023Q1 2023($0.58)($0.71)($0.13)($0.71)$13.00 million$13.55 million
3/31/2023Q4 2022($0.28)($0.54)($0.26)($0.54)$15.80 million$14.03 million
11/14/2022Q3 2022($0.37)($0.75)($0.38)($0.75)$15.60 million$13.60 million
7/27/2022Q2 2022($0.61)($0.45)+$0.16($0.45)$13.50 million$14.60 million    
5/9/2022Q1 2022($0.67)($0.85)($0.18)($0.85)$13.00 million$11.90 million    
2/24/2022Q4 2021($0.38)($0.59)($0.21)($0.59)$14.00 million$13.96 million    
10/27/2021Q3 2021($0.52)($0.60)($0.08)($0.60)$12.30 million$12.15 million    
8/13/2021Q2 2021$1.25$0.76($0.49)$0.49$23.30 million$21.70 million
4/27/2021Q1 2021($0.54)($0.63)($0.09)($0.63)$11.60 million$11.21 million  
2/23/2021Q4 2020($0.04)($0.18)($0.14)($0.18)$13.00 million$13.77 million  
11/2/2020Q3 2020($0.49)($0.12)+$0.37($0.12)$10.75 million$12.47 million    












Alimera Sciences Earnings - Frequently Asked Questions

When is Alimera Sciences's earnings date?

Alimera Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 13th, 2023 based off last year's report dates. Learn more on ALIM's earnings history.

Did Alimera Sciences beat their earnings estimates last quarter?

In the previous quarter, Alimera Sciences (NASDAQ:ALIM) missed the analysts' consensus estimate of $0.06 by $0.50 with a reported earnings per share (EPS) of ($0.44). Learn more on analysts' earnings estimate vs. ALIM's actual earnings.

How much revenue does Alimera Sciences generate each year?

Alimera Sciences (NASDAQ:ALIM) has a recorded annual revenue of $54.13 million.

How much profit does Alimera Sciences generate each year?

Alimera Sciences (NASDAQ:ALIM) has a recorded net income of -$18.11 million. ALIM has generated -$3.32 earnings per share over the last four quarters.

What is Alimera Sciences's EPS forecast for next year?

Alimera Sciences's earnings are expected to grow from ($0.01) per share to $0.39 per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:ALIM) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -